Literature DB >> 7409941

Sex-related variations in the frequency and characteristics of adverse drug reactions.

C Domecq, C A Naranjo, I Ruiz, U Busto.   

Abstract

Sex-related variations in the clinical effects of drugs may be observed. In an intensive prospective drug surveillance study of 1920 patients hospitalized at the Department of Medicine of the J. J. Aguirre Hospital in Santiago, Chile, the frequency of adverse drug reactions (ADR) was significantly higher in females than in males (p < 0.0005). Women presented more commonly gastrointestinal and cutaneous allergic reactions. In males electrolyte disturbances were more frequent. Drugs inducing ADR were very similar in both sexes. Eighty-three per cent of ADR in males and 93% in females were dose-related effects. Hospitalization was lengthened by a significantly higher proportion of ADR in men than in women. Other ADR's risk fators such as age, number of drugs administered and duration of hospitalization did not account for the differences observed. In males with ADR there was a higher proportion of patients with cirrhosis and renal insufficiency. These findings suggest that sex is a determinant of the frequency and characteristics of ADR.

Entities:  

Mesh:

Year:  1980        PMID: 7409941

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  18 in total

1.  Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies.

Authors:  C Noel Bairey Merz; Saralyn Mark; Barbara D Boyan; Alice K Jacobs; Prediman K Shah; Leslee J Shaw; Doris Taylor; Eduardo Marbán
Journal:  J Womens Health (Larchmt)       Date:  2010-06       Impact factor: 2.681

2.  Age- and gender-related differences in drug utilisation and adverse drug reaction patterns among patients in a coronary care unit.

Authors:  Nitin Subhashchandra Kunnoor; Padmini Devi; Deepak Yogesh Kamath; Naveen Anthony; Jesso George
Journal:  Singapore Med J       Date:  2014-04       Impact factor: 1.858

3.  Effects of antipsychotic treatment on psychopathology and motor symptoms. A placebo-controlled study in healthy volunteers.

Authors:  Tanja Veselinović; Holger Schorn; Ingo Vernaleken; Katharina Schiffl; Christoph Hiemke; Gerald Zernig; Ruben Gur; Gerhard Gründer
Journal:  Psychopharmacology (Berl)       Date:  2011-06-04       Impact factor: 4.530

Review 4.  Gender as a risk factor for adverse events to medications.

Authors:  J C Kando; K A Yonkers; J O Cole
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

5.  Drug prescribing for the elderly.

Authors:  P P Lamy
Journal:  Bull N Y Acad Med       Date:  1981-10

6.  Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram.

Authors:  Elise E DeVito; Theresa A Babuscio; Charla Nich; Samuel A Ball; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2014-10-20       Impact factor: 4.492

7.  Electrophysiological Neuroimaging using sLORETA Comparing 22 Age Matched Male and Female Schizophrenia Patients.

Authors:  Andy R Eugene; Jolanta Masiak; Jacek Kapica; Marek Masiak; Richard M Weinshilboum
Journal:  Hosp Chron       Date:  2015

8.  Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies.

Authors:  R M Martin; P N Biswas; S N Freemantle; G L Pearce; R D Mann
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

9.  Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals.

Authors:  Yurdaguel Zopf; Christina Rabe; Antje Neubert; Eckhart G Hahn; Harald Dormann
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

10.  Women encounter ADRs more often than do men.

Authors:  Y Zopf; C Rabe; A Neubert; K G Gassmann; W Rascher; E G Hahn; K Brune; H Dormann
Journal:  Eur J Clin Pharmacol       Date:  2008-07-05       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.